LIVN Q2 2023 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena

LIVNLivaNova PLC

$3B

Q2 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$294M+15.6% YoY

Gross Profit

$205M69.8% margin

Operating Income

$17M5.9% margin

Net Income

$1M0.4% margin

EPS (Diluted)

$0.02

QoQ Revenue Growth

+11.6%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$24M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$2.3B

Total Liabilities

$1.1B

Stockholders' Equity

$1.2B

Cash & Equivalents

$534M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$294M	$254M	+15.6%
Gross Profit	$205M	$184M	+11.3%
Operating Income	$17M	$32M	-45.3%
Net Income	$1M	$16M	-93.0%

Revenue Segments

Cardiopulmonary Segment

$151M51%

Neuromodulation Segment

$133M45%

Advanced Circulatory Support Segment

$9M3%

Geographic Segments

UNITED STATES

$160M54%

Locations Excluding The United States And Europe

$79M27%

Europe

$54M19%